Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CORTEX PHARMACEUTICALS INC Financial Overview

  • Income Statement: COR

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 0.00 0.00 0.00 N/A%
    Gross Profit -10.78 M -9.33 M -1.45 M 13.48%
    Net Income Before Extra Items/Preferred Div -14.60 M -12.97 M -1.63 M 11.14%
    Operating Income -15.04 M -13.65 M -1.39 M 9.25%
  • Cash Flow: COR

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 8,532.00 19.06 M -19.05 M -223,272.97%
    Net Cash Flow - Investing -10.45 M 5.94 M -16.39 M 156.90%
    Net Cash Flow/Operating Activities -13.05 M -10.74 M -2.30 M 17.66%
  • Balance Sheet: COR

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 5.15 M 18.43 M -13.28 M -257.68%
    Total Liabilities 1.76 M 1.75 M 3,794.00 0.22%
    Shareholders Equity 3.40 M 16.68 M -13.28 M -390.97%
  • Key Ratios / Statistics: COR

    • Valuation

      Price/Earnings (TTM) -1.85
      Price/Sales (TTM) 36.46
      Price/Book (MRQ) 39.58
      Price/Cash Flow (TTM) -0.83
    • Profitability

      Gross Margin -1,026.30
      Operating Margin -1,418.36
      Profit Margin -1,363.51
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 2.36
      Current Ratio (MRQ) 0.55
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -147.25
      Return on Assets (TTM) -99.66
      Return on Investments (TTM) -145.42